Shuttle Pharmaceuticals Holdings (SHPH) Net Cash Flow (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Net Cash Flow of $755941.0 for Q1 2026, down 70.84% year-over-year from $2.6 million in Q1 2025, and down 41.67% quarter-over-quarter from $1.3 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Net Cash Flow (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Net Cash Flow history runs 6 years deep, the most recent figure standing at $755941.0 for Q1 2026.
- In Q1 2026, Net Cash Flow fell 70.84% year-over-year to $755941.0; the TTM figure through Mar 2026 stood at -$365939.0 (down 111.75% YoY), while the FY2025 annual figure was -$1.6 million, down 141.69% from the prior year.
- Net Cash Flow for Q1 2026 stood at $755941.0, down from $1.3 million in the prior quarter.
- The five-year high for Net Cash Flow was $9.1 million in Q3 2022, with the low at -$2.7 million in Q3 2025.
- The 5-year median for Net Cash Flow is -$538938.0 (2024), against an average of $214230.5.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow slumped 1161.92% in 2023, then soared 320.11% in 2025.
- Shuttle Pharmaceuticals Holdings' Net Cash Flow stood at -$703187.0 in 2022, then plunged by 86.24% to -$1.3 million in 2023, then jumped by 234.66% to $1.8 million in 2024, then retreated by 26.5% to $1.3 million in 2025, then sank by 41.67% to $755941.0 in 2026.
- Business Quant data shows SHPH's Net Cash Flow at $755941.0 in Q1 2026, $1.3 million in Q4 2025, and -$2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 755,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,941.00 |
| Mar 31, 2026 | 755,941.00 |
| Dec 31, 2025 | 1.30 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | -2.72 Mn |
| Sep 30, 2025 | -2.72 Mn |
| Jun 30, 2025 | 305,065.00 |
| Jun 30, 2025 | 305,065.00 |
| Mar 31, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | -538,938.00 |
| Sep 30, 2024 | -538,938.00 |
| Jun 30, 2024 | -703,034.00 |
| Jun 30, 2024 | -703,034.00 |
| Mar 31, 2024 | -1.18 Mn |
| Mar 31, 2024 | -1.18 Mn |
| Dec 31, 2023 | -1.31 Mn |
| Dec 31, 2023 | -1.31 Mn |